154 related articles for article (PubMed ID: 19679828)
1. Liver X receptor-mediated induction of cholesteryl ester transfer protein expression is selectively impaired in inflammatory macrophages.
Lakomy D; Rébé C; Sberna AL; Masson D; Gautier T; Chevriaux A; Raveneau M; Ogier N; Nguyen AT; Gambert P; Grober J; Bonnotte B; Solary E; Lagrost L
Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1923-9. PubMed ID: 19679828
[TBL] [Abstract][Full Text] [Related]
2. Effect of macrophage overexpression of murine liver X receptor-alpha (LXR-alpha) on atherosclerosis in LDL-receptor deficient mice.
Teupser D; Kretzschmar D; Tennert C; Burkhardt R; Wilfert W; Fengler D; Naumann R; Sippel AE; Thiery J
Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2009-15. PubMed ID: 18787185
[TBL] [Abstract][Full Text] [Related]
3. Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand White rabbits.
Honzumi S; Shima A; Hiroshima A; Koieyama T; Terasaka N
Biochim Biophys Acta; 2011 Dec; 1811(12):1136-45. PubMed ID: 21875689
[TBL] [Abstract][Full Text] [Related]
4. Niacin reduces plasma CETP levels by diminishing liver macrophage content in CETP transgenic mice.
Li Z; Wang Y; van der Sluis RJ; van der Hoorn JW; Princen HM; Van Eck M; Van Berkel TJ; Rensen PC; Hoekstra M
Biochem Pharmacol; 2012 Sep; 84(6):821-9. PubMed ID: 22750059
[TBL] [Abstract][Full Text] [Related]
5. Arsenic trioxide suppresses liver X receptor β and enhances cholesteryl ester transfer protein expression without affecting the liver X receptor α in HepG2 cells.
Cheng TJ; Lin SW; Chen CW; Guo HR; Wang YJ
Chem Biol Interact; 2016 Oct; 258():288-96. PubMed ID: 27622732
[TBL] [Abstract][Full Text] [Related]
6. LXRalpha regulates human CETP expression in vitro and in transgenic mice.
Honzumi S; Shima A; Hiroshima A; Koieyama T; Ubukata N; Terasaka N
Atherosclerosis; 2010 Sep; 212(1):139-45. PubMed ID: 20494359
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Hepatic Cholesteryl Ester Transfer Protein Expression and Reverse Cholesterol Transport by Inhibition of DNA Topoisomerase II.
Liu M; Chen Y; Zhang L; Wang Q; Ma X; Li X; Xiang R; Zhu Y; Qin S; Yu Y; Jiang XC; Duan Y; Han J
J Biol Chem; 2015 Jun; 290(23):14418-29. PubMed ID: 25914138
[TBL] [Abstract][Full Text] [Related]
8. Important role for bone marrow-derived cholesteryl ester transfer protein in lipoprotein cholesterol redistribution and atherosclerotic lesion development in LDL receptor knockout mice.
Van Eck M; Ye D; Hildebrand RB; Kar Kruijt J; de Haan W; Hoekstra M; Rensen PC; Ehnholm C; Jauhiainen M; Van Berkel TJ
Circ Res; 2007 Mar; 100(5):678-85. PubMed ID: 17293475
[TBL] [Abstract][Full Text] [Related]
9. Cholesteryl ester transfer protein modulates the effect of liver X receptor agonists on cholesterol transport and excretion in the mouse.
Masson D; Staels B; Gautier T; Desrumaux C; Athias A; Le Guern N; Schneider M; Zak Z; Dumont L; Deckert V; Tall A; Jiang XC; Lagrost L
J Lipid Res; 2004 Mar; 45(3):543-50. PubMed ID: 14679166
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo.
Naik SU; Wang X; Da Silva JS; Jaye M; Macphee CH; Reilly MP; Billheimer JT; Rothblat GH; Rader DJ
Circulation; 2006 Jan; 113(1):90-7. PubMed ID: 16365197
[TBL] [Abstract][Full Text] [Related]
11. Liver X receptor and retinoic X receptor agonists modulate the expression of genes involved in lipid metabolism in human endothelial cells.
Norata GD; Ongari M; Uboldi P; Pellegatta F; Catapano AL
Int J Mol Med; 2005 Oct; 16(4):717-22. PubMed ID: 16142410
[TBL] [Abstract][Full Text] [Related]
12. Lipid transfer proteins: past, present and perspectives.
Quintão EC; Cazita PM
Atherosclerosis; 2010 Mar; 209(1):1-9. PubMed ID: 19733354
[TBL] [Abstract][Full Text] [Related]
13. Liver x receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways.
Ogawa D; Stone JF; Takata Y; Blaschke F; Chu VH; Towler DA; Law RE; Hsueh WA; Bruemmer D
Circ Res; 2005 Apr; 96(7):e59-67. PubMed ID: 15790955
[TBL] [Abstract][Full Text] [Related]
14. Activation of TRPV1 prevents OxLDL-induced lipid accumulation and TNF-α-induced inflammation in macrophages: role of liver X receptor α.
Zhao JF; Ching LC; Kou YR; Lin SJ; Wei J; Shyue SK; Lee TS
Mediators Inflamm; 2013; 2013():925171. PubMed ID: 23878415
[TBL] [Abstract][Full Text] [Related]
15. The orphan nuclear receptor LRH-1 potentiates the sterol-mediated induction of the human CETP gene by liver X receptor.
Luo Y; Liang CP; Tall AR
J Biol Chem; 2001 Jul; 276(27):24767-73. PubMed ID: 11331284
[TBL] [Abstract][Full Text] [Related]
16. Macrophage-independent regulation of reverse cholesterol transport by liver X receptors.
Breevoort SR; Angdisen J; Schulman IG
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1650-60. PubMed ID: 24947527
[TBL] [Abstract][Full Text] [Related]
17. Serum CETP status is independently associated with reduction rates in LDL-C in pitavastatin-treated diabetic patients and possible involvement of LXR in its association.
Shimada A; Kimura H; Oida K; Kanehara H; Bando Y; Sakamoto S; Wakasugi T; Saga T; Ito Y; Kamiyama K; Mikami D; Iwano M; Hirano T; Yoshida H
Lipids Health Dis; 2016 Mar; 15():57. PubMed ID: 26984517
[TBL] [Abstract][Full Text] [Related]
18. Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element.
Luo Y; Tall AR
J Clin Invest; 2000 Feb; 105(4):513-20. PubMed ID: 10683381
[TBL] [Abstract][Full Text] [Related]
19. Liver X receptor activation promotes polyunsaturated fatty acid synthesis in macrophages: relevance in the context of atherosclerosis.
Varin A; Thomas C; Ishibashi M; Ménégaut L; Gautier T; Trousson A; Bergas V; de Barros JP; Narce M; Lobaccaro JM; Lagrost L; Masson D
Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1357-65. PubMed ID: 25838428
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of cholesteryl ester transfer protein by glucocorticoids: a randomised study on HDL.
Werumeus Buning J; Dimova LG; Perton FG; Tietge UJF; van Beek AP; Dullaart RPF
Eur J Clin Invest; 2017 Jul; 47(7):494-503. PubMed ID: 28542805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
